Taking Stock of Current Options and Emerging Approaches for the Management of EoE

Program Overview

This 30-minute infographic-based educational activity reviews current therapies for eosinophilic esophagitis (EoE), as well as emerging conventional and biologic approaches for its treatment. This activity is also augmented by patient and clinician videos discussing available and investigational therapies.

Credit Expired

0.50 CE Credit(s)

Expires: May 30, 2022

Target Audience

This curriculum is designed for gastroenterologists, allergists and immunologists, pediatric gastroenterologists, pediatric allergists and immunologists, and NPs/PAs who diagnose and manage patients with eosinophilic esophagitis (EoE).

Educational Objectives

Upon completion of this activity, participants should be better able to:

Recognize the value and limitations of current eosinophilic esophagitis (EoE) management guidelines for children and adults
Assess pathophysiologic pathways and evaluate emerging targeted therapies for EoE

Activity Faculty

Evan S. Dellon, MD, MPH

Professor of Medicine, Adjunct Professor of Epidemiology
University of North Carolina School of Medicine
Chapel Hill, NC

Featured RMEI CE Activities

Climbing the Ladder to Optimal Outcomes in NTM-LD: Navigating a Clear Path from Diagnosis Thru Treatment

Halting the Vicious Vortex: Targeting Neutrophil Serine Protease Activation in Non-Cystic Fibrosis Bronchiectasis (NCFBE)

Tackling Treatment-Refractory and Drug-Resistant CMV in the Solid Organ Transplant Setting: A Care Team Forum®

Optimizing Biologic Therapy in Children with Moderate-to-Severe Atopic Dermatitis: A Care Team Forum®

Privacy | Terms of Use

Taking Stock of Current Options and Emerging Approaches for the Management of EoE

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Evan S. Dellon, MD, MPH

Climbing the Ladder to Optimal Outcomes in NTM-LD: Navigating a Clear Path from Diagnosis Thru Treatment

Halting the Vicious Vortex: Targeting Neutrophil Serine Protease Activation in Non-Cystic Fibrosis Bronchiectasis (NCFBE)

Tackling Treatment-Refractory and Drug-Resistant CMV in the Solid Organ Transplant Setting: A Care Team Forum®

Optimizing Biologic Therapy in Children with Moderate-to-Severe Atopic Dermatitis: A Care Team Forum®

Join Our Network

Company

CE Accreditation

HIPAA Verified & Compliant

Subscribe